Allogeneic Hematopoietic Cell Transplantation Using Post‐Transplant Cyclophosphamide in Patients With Large Paroxysmal Nocturnal Hemoglobinuria Clones
This study, representing the largest reported experience with PTCy-based HSCT for PNH, suggests that this platform is feasible and associated with excellent survival and a promising GvHD profile. These preliminary findings support further investigation of PTCy in transplant strategies for PNH.
Authors
- Bin Fu (ORCID: https://orcid.org/0000-0002-3119-7497)
- Zheng Wang (ORCID: https://orcid.org/0000-0003-4873-505X)
- Yú Chen (ORCID: https://orcid.org/0000-0003-2491-3974)
- Ling Nie (ORCID: https://orcid.org/0000-0002-7500-0983)
- Mingyang Deng (ORCID: https://orcid.org/0000-0003-3468-7173)
- Xin Li
- Ping Zhu
- Yajing Xu
- Qiangsheng Weng
- Can Liu
Institutions
- Central South University (CN)
- Hunan Provincial People's Hospital (CN)
- Chenzhou First People's Hospital (CN)
- Second Xiangya Hospital of Central South University (CN)
- Third Xiangya Hospital (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1111/ejh.70162
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00